Pharmacological management of bipolar disorder in a youth with diabetes

Journal of the American Academy of Child and Adolescent Psychiatry

Volumn 46, Issue 10, 2007, Pages 1375-1379

  DelBello, Melissa P ^a   Correll, Christoph U ^b   Carlson, Gabrielle A ^c   Carlson, Harold E ^d   Kratochvil, Christopher J ^e  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d STONY BROOK UNIVERSITY   (United States)

^e UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; MOOD STABILIZER; PLACEBO; QUETIAPINE; VALPROATE SEMISODIUM; VALPROIC ACID; ZIPRASIDONE;

BIPOLAR DEPRESSION; BIPOLAR DISORDER; CLINICAL TRIAL; DISEASE EXACERBATION; DRUG DOSE TITRATION; DRUG INDICATION; DRUG SAFETY; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; MAINTENANCE THERAPY; MANIA; METABOLIC DISORDER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; REVIEW; RISK BENEFIT ANALYSIS; STEVENS JOHNSON SYNDROME;

EID: 34648844246     PISSN: 08908567     EISSN: None     Source Type: Journal    
DOI: 10.1097/chi.0b013e31813c69c9     Document Type: Article

References (17)

1. Bergman RN, Ader M (2005), Atypical antipsychotics and glucose homeostasis. J Clin Psychiatr 66:504-514
2. Bowden CL, Calabrese JR, Ketter TA, Sachs GS, White RL, Thompson TR (2006), Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry 163: 1199-1201
3. Correll CU, Carlson HE (2006), Endocrine and metabolic adverse effects of psychotropic medications in children and adolescents. J Am Acad Child Adolesc Psychiatry 45:771-791
4. Correll CU, Leucht S, Kane JM (2004), Lower risk for tardive dyskinesia associated with second-generation antipsychotics: a systematic review of 1-year studies. Am J Psychiatry 161:414-425
5. Cramer JA, Rosenheck R (1998), Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 49:196-201
6. DelBello MP, Kowatch RA (2006), Pharmacological interventions for bipolar youth: developmental considerations. Dev Psychopathol 18: 1231-1246
7. Findling RL, McNamara NK, Youngstrom EA et al. (2005), Double-blind 18-month trial of lithium versus divalproex maintenance treatment in pediatric bipolar disorder. J Am Acad Child Adolesc Psychiatry 44: 409-417
8. Joffe H, Cohen LS, Suppes T et al. (2006), Longitudinal follow-up of reproductive and metabolic features of valrproate-associated polycystic ovarian syndrome features: a preliminary report. Biol Psychiatry 60: 1378-1381
9. Kowatch RA, Fristad M, Birmaher B et al. (2005), Treatment guidelines for children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 44:213-235
10. McClellan J, Kowatch R, Findling RL et al. (2007), Practice parameter for the assessment and treatment of children and adolescents with bipolar disorder. J Am Acad Child Adolesc Psychiatry 46:107-125
11. Pappadopulos E, Macintyre Ii JC, Crismon ML et al. (2003), Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part II. J Am Acad Child Adolesc Psychiatry 42:145-161
12. Ratzoni G, Gothelf D, Brand-Gothelf A et al. (2002), Weight gain associated with olanzapine and risperidone in adolescent patients: a comparative prospective study. J Am Acad Child Adolesc Psychiatry 41:337-343
13. Richardson MA, Haugland G, Craig TJ (1991), Neuroleptic use, parkinsonian symptoms, tardive dyskinesia, and associated factors in child and adolescent psychiatric patients. Am J Psychiatry 148: 1322-1328
14. Scherk H, Pajonk FG, Leucht S (2007), Second-generation antipsychotic agents in the treatment of acute mania: a systematic review and meta-analysis of randomized controlled trials. Arch Gen Psychiatry 64:442-455
15. Schur SB, Sikich L, Findling RL et al. (2003), Treatment recommendations for the use of antipsychotics for aggressive youth (TRAAY). Part I: a review. J Am Acad Child Adolesc Psychiatry 42:132-144
16. Urakami T, Morimoto S, Owada M, Harada K (2005), Usefulness of the addition of metformin to insulin in pediatric patients with type 1 diabetes mellitus. Pediatr Int 47:430-433
17. Zarate CA Jr, Tohen M (2004), Double-blind comparison of the continued use of antipsychotic treatment versus its discontinuation in remitted manic patients. Am J Psychiatry 161:169-171